drugset / Trial / NCT01743404

Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

NCT01743404 ↗

Phase 2 Unknown 300 enrolled Institute for Atherosclerosis Research, Russia
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to investigate the anti-atherosclerotic effect of long-term anti-inflammatory therapy (Inflaminat) in asymptomatic participants with subclinical atherosclerosis of carotid arteries.

Timeline

Start
2007-09
Primary completion
2013-02
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Inflaminat Unknown 500 mg Oral

Indications